Mahmood Hassan Dalhat

Title: Mahmood Hassan Dalhat: Innovator in Cancer Treatment

Introduction

Mahmood Hassan Dalhat is a notable inventor based in Jeddah, Saudi Arabia, recognized for his significant contributions to cancer research. With a focus on therapeutic compounds, Dalhat has made strides in the development of innovative treatments aimed at combating breast and pancreatic cancer.

Latest Patents

Dalhat holds one patent titled "Arylacetamides as AMP-activated protein kinase inhibitors and their use for treatment of breast cancer." This patent covers therapeutic compounds that incorporate an arylacetamide core with a pending N-benzyl group. Additionally, it describes pharmaceutical compositions utilizing these compounds and a method for inhibiting AMP-activated protein kinase (AMPK), emphasizing their potential use in treating breast and pancreatic cancers.

Career Highlights

Dalhat is affiliated with King Abdulaziz University, where he has contributed to the advancement of medical research through his innovative inventions. His work in this prestigious institution has positioned him as a leading figure in the field of therapeutic innovation, particularly concerning cancer treatment.

Collaborations

Throughout his career, Dalhat has collaborated with esteemed colleagues, including Abdelsattar Mansour Omar and Mohammad Imran Khan. These partnerships have facilitated the sharing of knowledge and resources, enriching the research environment at King Abdulaziz University and enhancing the development of cutting-edge therapeutic solutions.

Conclusion

Mahmood Hassan Dalhat's dedication to cancer research and innovation demonstrates the critical role inventors play in the medical field. His groundbreaking patent for arylacetamides reflects a commitment to improving treatment options for those affected by breast and pancreatic cancer, showcasing the potential impact of his work on future therapies.